Cat. #151136
Anti-nMyc [NMYC-1]
Cat. #: 151136
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 3-4 weeks
Target: nMyc
Class: Monoclonal
Application: ChIP ; IHC ; IF ; IP ; WB ; EMSA
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Gerard Evan
Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-nMyc [NMYC-1]
- Research fields: Cancer;Genetics
- Clone: NMYC-1
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 27 kDa
- Strain: Balb/c
- Reactivity: Human
- Host: Mouse
- Application: ChIP ; IHC ; IF ; IP ; WB ; EMSA
- Description: Diagnosis and prognosis in childhood neuroblastoma.
- Immunogen: Human N myc peptide sequence SPYVESEDAPPQKC conjugated to KLH.
- Immunogen uniprot id: P11487
- Isotype: IgG2b
- Myeloma used: Sp2/0-Ag14
Target Details
- Target: nMyc
- Molecular weight: 27 kDa
- Target background: Diagnosis and prognosis in childhood neuroblastoma.
Applications
- Application: ChIP ; IHC ; IF ; IP ; WB ; EMSA
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
References
- Tasseva et al. 2011. J Biol Chem. 286(2):1061-73. PMID: 21068393.
- N-Myc and SP regulate phosphatidylserine synthase-1 expression in brain and glial cells.
